Medunik Canada
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
950 Boul. Michèle-bohec, Blainville, Que...Phone Number
(844) 433-4441Website
www.medunikcanada.comRevenue
$18.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Medunik Canada
Médunik Canada is dedicated to providing access to orphan drugs for Canadians suffering from rare and debilitating diseases. The company develops and offers treatments that are not currently available in Canada, leveraging its state-of-the-art production facilities in Quebec. Through strategic partnerships and a commitment to research and development, Médunik Canada aims to enhance the quality of life for patients while contributing to the sustainability of the national economy. The company believes that all patients, regardless of the rarity of their condition, deserve effective treatment options.Explore more
Medunik Canada Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medunik Canada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Medunik Canada launches new products
Click to see if Medunik Canada had a recent Job posting/layoffs
Check if Medunik Canada has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Medunik Canada recently announced quarterly report
Medunik Canada, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Medunik Canada has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Medunik Canada
Check out if Medunik Canada is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Medunik Canada
Compare insights from companies similar to Medunik Canada, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medunik Canada is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medunik Canada is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medunik Canada.
Medunik Canada Tech Stack
A closer look at the technologies used by Medunik Canada
Medunik Canada News & Media
Medunik USA launches Pheburane® (sodium phenylbutyrate) oral pellets, a unique, taste-masked formulation of sodium phenylbutyrate (NaPB) used along with a specific diet for the long-term management of certain urea cycle disorders
Proven treatment option now available in U.S. in a palatable form taken by provided spoon and offered at a competitive price. Proven treatment option now available in U.S. in a palatable form taken by provided spoon and offered at a competitive price.Hydroxyurea-based treatment for sickle cell anemia previously available for pediatric patients now approved for use in adults
ROSEMONT, PA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Medunik USA is pleased to announce that Siklos® (hydroxyurea), previously indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises4, has now been approved for use in adults for the same indication.Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 100 mg scored tablets to help further optimize dosing
ROSEMONT, Pa., Oct. 19, 2020 /PRNewswire/ - Medunik USA is proud to announce that Siklos® (hydroxyurea), indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in children, 2 years of age and older, with sickle cell anemia with recurrent moderate...On World Sickle Cell Day, Medunik USA highlights the importance of early treatment of Sickle Cell Disease
ROSEMONT, PA, June 19, 2019 /PRNewswire/ - This World Sickle Cell Day, Medunik USA, a company dedicated to improving the health and quality of life of Americans with rare diseases, highlights the importance of early treatment of sickle cell disease. "Sickle cell disease is a destructive...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Medunik Canada
Sign Up For FreeTo access detailed company insights
Médunik Canada is dedicated to providing access to orphan drugs for Canadians suffering from rare and debilitating diseases. The company develops and offers treatments that are not currently available in Canada, leveraging its state-of-the-art production facilities in Quebec. Through strategic partnerships and a commitment to research and developme... Read More
